271 related articles for article (PubMed ID: 30737831)
1. Axis inhibition protein 1 (Axin1) Deletion-Induced Hepatocarcinogenesis Requires Intact β-Catenin but Not Notch Cascade in Mice.
Qiao Y; Wang J; Karagoz E; Liang B; Song X; Shang R; Evert K; Xu M; Che L; Evert M; Calvisi DF; Tao J; Wang B; Monga SP; Chen X
Hepatology; 2019 Dec; 70(6):2003-2017. PubMed ID: 30737831
[TBL] [Abstract][Full Text] [Related]
2. Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation-driven hepatocarcinogenesis.
Liang B; Wang H; Qiao Y; Wang X; Qian M; Song X; Zhou Y; Zhang Y; Shang R; Che L; Chen Y; Huang Z; Wu H; Monga SP; Zeng Y; Calvisi DF; Chen X; Chen X
Hepatology; 2023 Jun; 77(6):1929-1942. PubMed ID: 35921500
[TBL] [Abstract][Full Text] [Related]
3. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
4. TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis.
Liang B; Zhou Y; Qian M; Xu M; Wang J; Zhang Y; Song X; Wang H; Lin S; Ren C; Monga SP; Wang B; Evert M; Chen Y; Chen X; Huang Z; Calvisi DF; Chen X
J Hepatol; 2021 Jul; 75(1):120-131. PubMed ID: 33577921
[TBL] [Abstract][Full Text] [Related]
5. Conditional disruption of Axin1 leads to development of liver tumors in mice.
Feng GJ; Cotta W; Wei XQ; Poetz O; Evans R; Jardé T; Reed K; Meniel V; Williams GT; Clarke AR; Dale TC
Gastroenterology; 2012 Dec; 143(6):1650-9. PubMed ID: 22960659
[TBL] [Abstract][Full Text] [Related]
6. Targeting β-catenin in hepatocellular cancers induced by coexpression of mutant β-catenin and K-Ras in mice.
Tao J; Zhang R; Singh S; Poddar M; Xu E; Oertel M; Chen X; Ganesh S; Abrams M; Monga SP
Hepatology; 2017 May; 65(5):1581-1599. PubMed ID: 27981621
[TBL] [Abstract][Full Text] [Related]
7. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
[TBL] [Abstract][Full Text] [Related]
8. CCAAT/enhancer-binding protein-β functions as a negative regulator of Wnt/β-catenin signaling through activation of AXIN1 gene expression.
Park S; Lee MS; Gwak J; Choi TI; Lee Y; Ju BG; Kim CH; Oh S
Cell Death Dis; 2018 Oct; 9(10):1023. PubMed ID: 30283086
[TBL] [Abstract][Full Text] [Related]
9. RSK2 inactivation cooperates with AXIN1 inactivation or β-catenin activation to promote hepatocarcinogenesis.
Schaeffer S; Gupta B; Calatayud AL; Calderaro J; Caruso S; Hirsch TZ; Pelletier L; Zucman-Rossi J; Rebouissou S
J Hepatol; 2023 Sep; 79(3):704-716. PubMed ID: 37201672
[TBL] [Abstract][Full Text] [Related]
10. β-Catenin signaling in hepatocellular carcinoma.
Xu C; Xu Z; Zhang Y; Evert M; Calvisi DF; Chen X
J Clin Invest; 2022 Feb; 132(4):. PubMed ID: 35166233
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic STRAP Supports Hepatocellular Carcinoma Growth by Enhancing Wnt/β-Catenin Signaling.
Wang W; Li S; Liu P; Sideras K; van de Werken HJG; van der Heide M; Cao W; Lavrijsen M; Peppelenbosch MP; Bruno M; Pan Q; Smits R
Mol Cancer Res; 2019 Feb; 17(2):521-531. PubMed ID: 30257989
[TBL] [Abstract][Full Text] [Related]
12. Alterations of axis inhibition protein 1 (AXIN1) in hepatitis B virus-related hepatocellular carcinoma and overexpression of AXIN1 induces apoptosis in hepatocellular cancer cells.
Li J; Quan H; Liu Q; Si Z; He Z; Qi H
Oncol Res; 2013; 20(7):281-8. PubMed ID: 23879168
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the Extracellular Matrix Progressively Impairs Central Nervous System Vascular Maturation Downstream of β-Catenin Signaling.
Jensen LD; Hot B; Ramsköld D; Germano RFV; Yokota C; Giatrellis S; Lauschke VM; Hubmacher D; Li MX; Hupe M; Arnold TD; Sandberg R; Frisén J; Trusohamn M; Martowicz A; Wisniewska-Kruk J; Nyqvist D; Adams RH; Apte SS; Vanhollebeke B; Stenman JM; Kele J
Arterioscler Thromb Vasc Biol; 2019 Jul; 39(7):1432-1447. PubMed ID: 31242033
[TBL] [Abstract][Full Text] [Related]
14. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of AXIN1 and AXIN2 as targets of tankyrase inhibition in hepatocellular carcinoma cell lines.
Wang W; Liu P; Lavrijsen M; Li S; Zhang R; Li S; van de Geer WS; van de Werken HJG; Peppelenbosch MP; Smits R
Sci Rep; 2021 Apr; 11(1):7470. PubMed ID: 33811251
[TBL] [Abstract][Full Text] [Related]
16. Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.
Kim YD; Park CH; Kim HS; Choi SK; Rew JS; Kim DY; Koh YS; Jeung KW; Lee KH; Lee JS; Juhng SW; Lee JH
J Gastroenterol Hepatol; 2008 Jan; 23(1):110-8. PubMed ID: 18171349
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic potential of N-terminal deletion and S45Y mutant β-catenin in promoting hepatocellular carcinoma development in mice.
Qiao Y; Xu M; Tao J; Che L; Cigliano A; Monga SP; Calvisi DF; Chen X
BMC Cancer; 2018 Nov; 18(1):1093. PubMed ID: 30419856
[TBL] [Abstract][Full Text] [Related]
18. LKB1 signaling is activated in CTNNB1-mutated HCC and positively regulates β-catenin-dependent CTNNB1-mutated HCC.
Charawi S; Just PA; Savall M; Abitbol S; Traore M; Metzger N; Ravinger R; Cavard C; Terris B; Perret C
J Pathol; 2019 Apr; 247(4):435-443. PubMed ID: 30566242
[TBL] [Abstract][Full Text] [Related]
19. FAK is required for c-Met/β-catenin-driven hepatocarcinogenesis.
Shang N; Arteaga M; Zaidi A; Stauffer J; Cotler SJ; Zeleznik-Le NJ; Zhang J; Qiu W
Hepatology; 2015 Jan; 61(1):214-26. PubMed ID: 25163657
[TBL] [Abstract][Full Text] [Related]
20. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
